
Megestrol Acetate Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 20 mg, 40 mg, 160 mg, 625 mg
Reference Brands: Megace(US & EU), Megestat®, Megaplex®, Megacephin®(EU)
Category: Oncology Cancer Care
Megestrol Acetate is available in Tablet and strengths such as 20 mg, 40 mg, 160 mg, 625 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Megestrol Acetate is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
Technical Specifications & Supply Details | |
---|---|
Lead Time | 7 to 60 days (depending on batch size & schedule) |
MOQ | As per manufacturer’s batch size |
COA | Available with every batch |
Regulatory Dossier / DMF | Available upon request |
Export Documentation | FSC, COA, Manufacturing License, Product Permission |
Standards | IP, BP, USP |
Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Megestrol Acetate can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Product Description: Megestrol Acetate Tablets are oral hormone-based therapies widely used in oncology for treating advanced breast and endometrial cancers, as well as cancer-related cachexia. Available in 20 mg, 40 mg, 160 mg, and 625 mg strengths, Megestrol Acetate is approved in both the U.S. and EU markets. It works by modifying hormone levels to inhibit cancer cell growth and stimulate appetite in patients suffering from weight loss. A key product in oncology B2B distribution, Megestrol Acetate is essential for improving quality of life and managing hormone-responsive cancers and cancer-induced anorexia.
Frequently Asked Questions
Related Products
Atezolizumab
Strength: 1200 mg/20 mL
Form: Intravenous infusion
Reference Brands: Tecentriq® (EU & US)
View DetailsDurvalumab
Strength: 120 mg/4 mL, 500 mg/10 mL
Form: Injection
Reference Brands: Imfinzi® (US & EU)
View DetailsSunitinib
Strength: 12.5 mg, 25 mg, 37.5 mg, 50 mg
Form: Tablet
Reference Brands: Sutent® (EU & US)
View DetailsQuick Response Guaranteed | Verified Suppliers